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Although in vitro models of human hepatitis B virus replication are established, so far 
none could approximate infection efficiency as expected from in vivo observations. 
Susceptibility for HBV infections has only been reported for primary hepatocytes of 
human, chimpanzee or Tupaia belangeri and the cell line HepaRG. Here we show that the 
insusceptible human hepatoma cell line HepG2 can be infected, when the virus was 
beforehand activated by passage over whole duck liver cell cultures. That suggests an 
activation step to be performed by specialized liver cells.  
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The hepatitis B virus (HBV) is a small single stranded DNA-containing enveloped virus. 
Depending on its relatively strict organotropicity HBV infects mainly hepatocytes and 
causes severe liver diseases in humans 
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1. For this reason it was so far only possible to 
infect in vitro cultures of primary human or Tupaia belangeri hepatocytes 2,3, whereas 
human hepatoma cell lines are usually refractory to HBV infection. We succeeded in 
infecting the hepatoma cell line HepG2 with HBV by ‘activating’ the virus in a culture of 
primary duck liver cells (PDLCs).  
Using duck HBV (DHBV)-infected PDLCs as a model data were published indicating 
that eventually scavenging liver sinusoidal endothelial cells (LSECs) play the key role in 
the initial uptake and targeting of hepadnaviruses in the liver 4. These data implicated that 
in the process of transcytosis through LSECs the viral surface of HBV may be altered as 
a prerequisite for the infection procedure, a step that may be limiting for the infection of 
hepatoma cell lines like HepG2 (Fig. 1b).  Further in vitro experiments performed in our 
laboratory using preparations of embryonal PDLCs 5,6 infected with purified DHBV 
virions 7 revealed that at least co-staining of single LSECs could be measured using 
fluorescence-labeled acetylated low density lipoprotein for the identification of LSECs 
and anti-DHBc antibodies for the localization of the virions (not shown). Taking into 
account a possibly high conservation of LSEC function we predicted that the human 
HBV could also be found in association with LSECs in a duck liver cell culture. Indeed, 
immunofluorescence studies performed with rabbit antisera against HBc or the human 
nuclear factor of activated T cells (NFATc1; Santa Cruz) as a marker of LSECs revealed 
24 h after the addition of HBV, similarly as described for DHBV-infected PDLCs 8, co-
localization of HBV and NFATc1 in a PDLC culture (Fig. 1a). Cells, negative for 
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NFATc1 but strongly reacting with anti-HBc antiserum, are possibly Kupffer cells with 
their typical phagocytic activity. As a source of HBV virions, HepG2.2.15 cells, HepG2 
cells stably transfected with cloned HBV-DNA, were utilized for the production of 
infectious HBV 
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9, which was concentrated 50-fold from the collected supernatants 10.  
The calculation of virions was performed by DNA dot blot, using a gel-purified full-
length EcoRI fragment of cloned HBV DNA labeled with [α-32P] dCTP as a probe 6. 
When we measured the amount of virions after the passage through a PDLC culture, 
designated as HBV*, against the initial amount of HBV, we found a reduction of about 
60 %, supposedly lost by unspecific adsorption and phagocytosis (Fig. 1c). In order to 
test the infectivity of HBV* for HepG2 cells after passage through primary duck LSECs, 
a time course kinetic for the release of virions after infection was performed (Fig. 2a). It 
revealed a steady increase of the amount of viral DNA (again measured by dot blot) in 
the supernatants of HepG2 cells, comparable to the cell growth-dependent increase of 
viral output in the stably transfected hepatoma cell line HepG2.2.15. Otherwise, no viral 
DNA could be detected in the supernatants when untreated HBV was used directly for 
infection. To study viral DNA replication in infected HepG2 cells in more details we 
performed a Southern blot using the same radioactively labeled probe as described above. 
Besides the full-length relaxed circular DNA single-stranded replicative intermediates of 
HBV DNA were also detected (Fig. 2b). In this study we could find out three further 
details: first, an incubation time of HBV with LSECs of 24 h instead of 4 h did not lead to 
an increase of infectivity; second, transfer of HBV-incubated activator cells instead of 
activated virus was also able to initiate HBV-infection; third, to employ another cell type, 
primary duck kidney cells 8, as activator cells would not support subsequent infection of 
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hepatoma cell lines.  In a next experiment we replaced every 24 h the culture medium of 
HBV infected HepG2 cells for the calculation of the amount of the viral surface proteins 
with a commercially available anti-HBs-coated micro particle enzyme immunoassay 
(Abbott AXSYM system, Germany) as a measure of virus production per day (Fig. 2c). 
Seven days after infection the cells were disrupted to reveal HBV proteins after 
electrophoretical separation over a 5 to 20 % polyacrylamide gradient by Western blots 
with rabbit antisera raised against the surface proteins (HBs) or the core protein (HBc) of 
HBV as described 
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6. Only in HBV*-infected cultures the synthesis of HBV core and 
surface proteins could be demonstrated by immunoblotting (Fig. 2d). The alteration HBV 
virions acquire during passage through PDLC cultures would supposedly concern 
envelope protein integrity or reversible modification. We therefore compared their 
appearance in immunoblotting. The general glycosylation pattern of the viral envelope 
proteins of HBV and HBV* was unchanged. Yet, we found the amount of the 
unglycosylated small surface protein of HBV to be significantly reduced; whereas the 
glycosylated as well as the unglycosylated middle and large surface proteins did not show 
particular alterations (Fig. 1d). 
We conclude that hepatoma cell lines like HepG2 are susceptible to infection with HBV 
after a yet to define activation step for HBV virions that takes place in whole liver cell 
cultures and may even play a significant role in physiological HBV infections. The main 
suspect for HBV activation would be LSECs as they constitute a permeable barrier 
between the blood stream and the liver parenchyma and thus necessarily come into close 
contact with trespassing particles 11. The absence of morphological features comparable 
to the liver architecture in cell cultures or defined conditions for the maintenance of 
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specialized cell types may be the major player that hampers in vitro hepadnaviral 
infections. Another possibility to influence infectivity of HBV virions would only be 
secretion of relevant molecules by a cell type in the culture. The establishment of pure 
LSEC cultures or LSEC cell lines and close pursuance of viral particles within the cells 
will permit to throw light on their participation in the proposed viral activation. 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
127 
128 
129 
130 
131 
132 
133 
134 
135 
136 
137 
138 
 
 
 
This work was supported by the grant Br 899/4-1 from the Deutsche 
Forschungsgemeinschaft and the Bundesministerium für Bildung, Wissenschaft, 
Forschung und Technologie. The Heinrich-Pette-Institut is supported by the Freie und 
Hansestadt Hamburg and the Bundesministerium für Gesundheit. 
 
 
 
 
 
 
 
 
 
 
 
 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
07
.2
21
.1
 : 
Po
st
ed
 2
5 
Ju
n 
20
07
 7
139 
140 
141 
142 
143 
144 
145 
146 
147 
148 
149 
150 
151 
152 
153 
154 
155 
156 
157 
158 
159 
160 
161 
162 
163 
164 
165 
166 
167 
168 
169 
170 
171 
172 
173 
174 
175 
176 
References 
 
1. Ganem, D. in Fields Virology (eds. Fields, B. N., Knipe, D. M. & Howley, P. M.) 
2703-2737 (Lippincott-Raven, Philadelphia, 1996). 
2. Gripon, P. et al. Hepatitis B virus infection of adult human hepatocytes cultured in 
the presence of dimethyl sulfoxide. J Virol 62, 4136-43 (1988). 
3. Walter, E., Keist, R., Niederost, B., Pult, I. & Blum, H. E. Hepatitis B virus 
infection of tupaia hepatocytes in vitro and in vivo. Hepatology 24, 1-5 (1996). 
4. Breiner, K. M., Schaller, H. & Knolle, P. A. Endothelial cell-mediated uptake of a 
hepatitis B virus: a new concept of liver targeting of hepatotropic 
microorganisms. Hepatology 34, 803-8 (2001). 
5. Kock, J. & Schlicht, H. J. Analysis of the earliest steps of hepadnavirus 
replication: genome repair after infectious entry into hepatocytes does not depend 
on viral polymerase activity. J Virol 67, 4867-74 (1993). 
6. Bruns, M., Miska, S., Chassot, S. & Will, H. Enhancement of hepatitis B virus 
infection by noninfectious subviral particles. J Virol 72, 1462-8 (1998). 
7. Franke, C., Matschl, U. & Bruns, M. Enzymatic treatment of duck hepatitis B 
virus: Topology of the surface proteins for virions and noninfectious subviral 
particles. Virology 359, 126-137 (2007). 
8. Maenz, C., Chang, S.-F., Iwanski, A. & Bruns, M. Entry of duck hepatitis B virus 
into primary duck liver and kidney cells after discovery of a fusogenic region 
within the large surface protein. J Virol 81, 5014-5023 (2007). 
9. Sells, M. A., Chen, M. L. & Acs, G. Production of hepatitis B virus particles in 
Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci 
U S A 84, 1005-9 (1987). 
10. Gripon, P. et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc 
Natl Acad Sci U S A 99, 15655-60 (2002). 
11. Wisse, E., De Zanger, R. B., Charels, K., Van Der Smissen, P. & McCuskey, R. 
S. The liver sieve: considerations concerning the structure and function of 
endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology 5, 
683-92 (1985). 
 
 
 
 
 
 
 
 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
07
.2
21
.1
 : 
Po
st
ed
 2
5 
Ju
n 
20
07
 8
177 
178 
179 
180 
181 
182 
183 
184 
185 
186 
187 
188 
189 
190 
191 
192 
193 
194 
195 
196 
197 
198 
199 
 
 
 
 
Figure Legends 
 
Fig. 1. Activation of HBV by PDLCs for infection of human hepatoma cells. (a) Co-
immunofluorescence staining of PDLCs after incubation with HBV using anti-HBc and 
anti-NFATc1 antisera. (b) Model to demonstrate the requirement for activation of HBV 
by PDLCs before the infection of target cells like HepG2. (c) Analysis of HBV DNA 
before and after the addition to PDLCs. HBV was added to PDLCs and removed again 
after an incubation time of 4 h. Calculation of the viral DNAs before and after incubation 
with PDLCs revealed a loss of HBV virions of about 60 %; the presented dot blot data 
shows the mean of 3 measurements. (d) The same amount of virus particles was used to 
investigate changes of the viral envelope proteins before and after incubation with 
PDLCs; GP, glycoprotein, and P, protein, indicate the molecular weight in kD of the 
HBV large (L), middle (M), and small surface proteins (S). 
Fig. 2. Study of viral DNA replication and protein synthesis in HepG2 cells. (a) Dot blot 
kinetic of viral DNA in the supernatants over 7 days following infection of HepG2 cells 
with HBV* and HBV or seeding of HepG2.2.15 cells. (b) Infectivity of HBV* for HepG2 
cells; prior incubation of HBV with PDLCs was performed for 4 or 24 h (lanes 2 and 3). 
Alternatively HBV-treated PDLCs or primary duck kidney cells were transferred into the 
HepG2 culture (lanes 5 and 6); lane 1, HepG2.2.15 cells; RC, relaxed circular, and SS, 
 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
07
.2
21
.1
 : 
Po
st
ed
 2
5 
Ju
n 
20
07
 9
200 
201 
202 
203 
204 
205 
206 
single-stranded, DNAs of HBV; M, viral marker DNA. (c) Kinetic study of HBs for one 
week; here, day 1 represents viral input. All data points represent the mean of 3 
calculations. (d) Analysis of the production of viral surface (left) or core (21.5 kD) 
proteins (right) by Western blot one week after infection with HBV* or HBV; mock*- 
and mock-treated inputs refer to the supernatants of HepG2 cells similarly passaged over 
PDLCs or not; P, PDLCs after removal of HBV*.  
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Fig. 1. Maenz & Bruns 
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Fig. 2. Maenz  & Bruns 
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